Global Point Of Care
Global Point Of Care
Unlock the potential in pediatric testing by screening to the NIH guidelines and reducing the risk associated with early CVD. Screen early for detection of familial hypercholestrolemia (FH) with the Cholestech LDXTM System. Contact us today to start pediatric lipid testing.
Reducing lifetime risk for cardiovascular disease (CVD) is the principle that underlies CVD prevention strategies, including those that begin in childhood.1 The big five heart disease and stroke factors (high blood pressure, high cholesterol, smoking or secondhand smoke, an unhealthy diet and physical inactivity) are rooted in childhood.2
Universal cholesterol screenings of children from ages 9-11, not only enables physicians to work with their patients and the child's caregiver to address any modifiable risk factors, but it also screens for the presence of familial hypercholesterolemia. Only 4-5% of children between 9-11 years of age are being screened.3
The NIH guidelines offer the most comprehensive and up-to-date approach to pediatric lipid screening, helping clinicians improve outcomes
The Cholestech LDX system uses a small, fingerstick sample, testing for lipids and glucose right at the point of care. This enables pediatricians and parents to have face-to-face conversations about modifiable or genetic risk factors.
Reliable and fast, the Cholestech LDX system has been the #1 choice for fingerstick lipid testing by healthcare professionals for over 25 years.
Small 40 μL fingerstick sample
Convenient for kids, parents and HCPs
Accurate, reliable results in 5 minutes
The Cholestech LDX system uses a small, fingerstick sample, testing for lipids and glucose right at the point of care. This enables pediatricians and parents to have face-to-face conversations about modifiable or genetic risk factors.
Reliable and fast, the Cholestech LDX system has been the #1 choice for fingerstick lipid testing by healthcare professionals for over 25 years.
Small 40 μL fingerstick sample
Convenient for kids, parents and HCPs
Accurate, reliable results in 5 minutes
Familial hypercholesterolemia (FH) is a common genetic disorder leading to elevated low density lipoprotein cholesterol (LDL-C) from birth.4 Globally 1 out of 220 children, approximately one child has FH, and therefore an increased risk to suffer from early cardiovascular disease, or even early death.5
Cholestech LDX is not for use in children under the age of 2 years or patients with hyperbilirubinemia (elevated bilirubin levels).
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions, Privacy Policy, and Consumer Health Data Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.